Healthcare -
Biotechnology - NASDAQ - US
$ 8.03
2.29 %
$ 178 M
Market Cap
-3.68
P/E
Price Target
Average
173.97%
Revenue Forecast
Estimate
511.29%
EBIT
Estimate
0.64%
Net Income
Estimate
13.04%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
INmune Bio, Inc.
Wall Street analysts predict an average 1-year price target for INMB of $22 , with forecasts ranging from
a
low of
$22 to a high of $22 .
INMB Lowest Price Target
Wall Street Target
22 USD
173.97%
INMB Average Price Target
Wall Street Target
22 USD
173.97%
INMB Highest Price Target
Wall Street Target
22 USD
173.97%
REVENUE FORECAST
Revenue Forecast Chart INMB
EBIT FORECAST
EBIT Forecast Chart INMB
NET INCOME FORECAST
Net Income Chart INMB